Highlights and Quick Summary
- Equity Repurchase (Common, Net) for the quarter ending December 31, 2022 was $0 (a -100.0% decrease compared to previous quarter)
- Year-over-year quarterly Equity Repurchase (Common, Net) decreased by -100.0%
- Annual Equity Repurchase (Common, Net) for 2021 was $25.8 Million (a 1044.44% increase from previous year)
- Annual Equity Repurchase (Common, Net) for 2020 was $2.25 Million (a -67.1% decrease from previous year)
- Annual Equity Repurchase (Common, Net) for 2018 was $6.84 Million (a 12.37% increase from previous year)
- Twelve month Equity Repurchase (Common, Net) ending December 31, 2022 was $32.1 Million (a -26.34% decrease compared to previous quarter)
- Twelve month trailing Equity Repurchase (Common, Net) increased by 180.24% year-over-year
Trailing Equity Repurchase (Common, Net) for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '21 | 31 Mar '21 |
|---|---|---|---|
| $32.1 Million | $43.6 Million | $25.8 Million | $11.5 Million |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Equity Repurchase (Common, Net) of Benitec Biopharma Limited
Most recent Equity Repurchase (Common, Net)of BNTC including historical data for past 10 years.Interactive Chart of Equity Repurchase (Common, Net) of Benitec Biopharma Limited
Benitec Biopharma Limited Equity Repurchase (Common, Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | $0.0 | $17.88 | – |
| 2021 | – | – | $14.25 | $0.0 | $25.75 |
| 2020 | – | $11.49 | $0.0 | $-0.03 | $2.25 |
| 2019 | – | – | $0.03 | $2.25 | – |
| 2018 | – | – | – | – | $6.84 |
| 2017 | – | – | – | – | $6.09 |
| 2016 | – | – | – | – | $14.18 |
| 2015 | – | – | – | – | $0.32 |
| 2014 | – | – | – | – | $35.88 |
| 2013 | – | – | – | – | $1.12 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology